Overall rank by patents
#20,927
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 3 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
According to USPTO PatentsView, Cibus ranks #20,927 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 3 technology areas.
USPTO PatentsView assignee plate
Corpus R20927 · Foreign Corporation #20,927 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Chordate Medical AB (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Cibus Europe B v · this assignee
31 score
3D Lighting Innovati… · lowest
7 score
What this shows Cibus's Innovation Score is 30.6/100 (top 65% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Cibus Europe B.v. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2017. By volume, Cibus sits between Chordate Medical AB and Clarcor Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CHORDATE MEDICAL AB
13 patents
CHUBU UNIVERSITY EDUCATIONAL FOUNDATION
13 patents
CHUGAI RO CO., LTD.
13 patents
CI SYSTEMS (ISRAEL) LTD.
13 patents
CIROCOMM TECHNOLOGY CORP.
13 patents
CIVCO Medical Instruments Co., Inc.
13 patents
CLAM CORPORATION
13 patents
CLARCOR Inc.
13 patents
CIBUS EUROPE B.V.
13 patents
What this shows Cibus holds 13 patents at rank #20,906, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,906 in granted patent volume.
Other assignees with the most granted patents in Cibus's primary technology class.
Cibus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 Top 65% higher than 35% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 7.7% |
| 2018 | 1 | 7.7% |
| 2019 | 1 | 7.7% |
| 2020 | 2 | 15.4% |
| 2021 | 2 | 15.4% |
| 2022 | 3 | 23.1% |
| 2023 | 2 | 15.4% |
| 2025partial year | 1 | 7.7% |
Top 3 of 3 technology areas
Overall rank by patents
#20,927
of 50,000 tracked assignees
30.6 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.